Etanercept (Enbrel?) is a therapeutic fusion protein specific for Tumor Necrosis Factor-Alpha (TNF-α) and is used to treat rheumatic arthritis, intestinal disorders, dermatological diseases and cancer. Etanercept specifically binds to TNF alpha and blocks its interaction with cell surface TNF receptors and reduces the inflammation and subsequently improves the patient's health. However, some patients develop unwanted immunogenicity, which leads to production of anti-drug-antibodies (ADAs) inactivating the therapeutic effects of the treatment and, in rare cases, inducing adverse effects. BioVision's BioSimTM anti-Etanercept ELISA kit is designed to detect the antibody against Etanercept with high specificity and sensitivity in biol
Size
100 assays
Concentration
n/a
Applications
This ELISA kit is used for Qualitative determination of antibody against Etanercept in serum and plasma